570 — China Traditional Chinese Medicine Holdings Co Balance Sheet
0.000.00%
- HK$9.11bn
- HK$9.12bn
- CNY14.74bn
Annual balance sheet for China Traditional Chinese Medicine Holdings Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | HKAS | HKAS | HKAS | HKAS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 4,141 | 3,670 | 3,904 | 5,336 | 5,050 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 8,794 | 7,992 | 9,553 | 8,498 | 8,844 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 18,203 | 17,967 | 19,800 | 18,840 | 17,708 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 7,866 | 7,924 | 7,960 | 7,714 | 7,188 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 36,389 | 35,637 | 37,068 | 35,064 | 32,347 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 8,765 | 10,103 | 9,333 | 7,800 | 7,734 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 16,671 | 15,469 | 15,908 | 13,860 | 11,878 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 19,719 | 20,168 | 21,160 | 21,204 | 20,470 |
| Total Liabilities & Shareholders' Equity | 36,389 | 35,637 | 37,068 | 35,064 | 32,347 |
| Total Common Shares Outstanding |